Showing results (1-10 of 306) with videos related to
Sort By:
Pageof 31
Gastroenterology Report|November 9, 2020
Cronkhite-Canada syndrome: from clinical features to treatmentZe-Yu Wu, Li-Xuan Sang, Bing ChangWorld Journal of Clinical Cases|June 18, 2020
Isoflavones and inflammatory bowel diseaseZe-Yu Wu, Li-Xuan Sang, Bing ChangWorld Journal of Gastroenterology|November 4, 2024
Elafibranor: A promising treatment for alcohol-associated liver disease?Hong Wei, Li-Xuan Sang, Bing ChangWorld Journal of Gastrointestinal Surgery|March 10, 2023
Fecal microbiota transplantation as potential first-line treatment for patients with <i>Clostridioides difficile</i> infection and prior appendectomyJing-Wen Zhao, Bing Chang, Li-Xuan SangWorld Journal of Gastroenterology|July 10, 2024
Gastric microbiota transplantation as a potential treatment for immune checkpoint inhibitor-associated gastritisBo-Tong Ma, Li-Xuan Sang, Bing ChangWorld Journal of Gastroenterology|February 5, 2024
Use of curcumin and its nanopreparations in the treatment of inflammatory bowel diseaseZi-Wen Meng, Bing Chang, Li-Xuan SangWorld Journal of Gastroenterology|January 8, 2024
Potential therapeutic targets for nonalcoholic fatty liver disease: Glucagon-like peptide 1Yue-Hua Yin, Li-Xuan Sang, Bing ChangWorld Journal of Gastroenterology|December 14, 2020
Pituitary stalk interruption syndrome and liver changes: From clinical features to mechanismsZe-Yu Wu, Yi-Ling Li, Bing ChangBMC Gastroenterology|February 26, 2013
Consumption of coffee associated with reduced risk of liver cancer: a meta-analysisLi-Xuan Sang, Bing Chang, Xiao-Hang Li, et al.World Journal of Gastroenterology|April 8, 2021
Primary localized gastric amyloidosis: A scoping review of the literature from clinical presentations to prognosisXin-Yu Lin, Dan Pan, Li-Xuan Sang, et al.Pageof 31